The company designed its advanced, dual-head SPECT/CT technology to enhance diagnostic capabilities and streamline workflows. It offers clinicians high-quality imaging and operational efficiency.
GE HealthCare says that clinicians now require more advanced SPECT/CT solutions providing greater diagnostic accuracy and efficiency. Monitoring and tailoring treatments to individual patients depends on high-quality imaging that can detect subtle disease markers.
To meet evolving healthcare needs, the company said it aims for Aurora and Clarify DL to seamlessly integrate into various clinical settings. This ensures that hospitals and imaging centers can adopt them without disrupting existing workflows.
Aurora provides imaging precision, streamlines workflows and enables an improved patient experience. GE HealthCare says it marks a significant step forward in nuclear medicine. It features a 40 mm detector, bringing twice the detector coverage compared to CTs of other hybrid systems. The system also has intelligent imaging capabilities to support a range of clinical applications from cardiology to oncology and neurology.
Clarity DL — designed to build on Aurora’s performance — uses deep learning AI to enhance bone SPECT image quality performance. GE HealthCare said its image resolution was rated as “better” in 98% of clinical evaluation exams, demonstrating its potential in nuclear medicine.
“Aurora and Clarify DL are powerful reflections of GE HealthCare’s ongoing investment in next-generation imaging solutions that empower clinicians to practice precision medicine and make more informed decisions,” says Jean-Luc Procaccini, president and CEO, Molecular Imaging and Computed Tomography, GE HealthCare. “By providing diagnostic precision while enabling improved workflow, these nuclear medicine technologies allow clinicians to deliver effective, patient-centered care—ultimately helping drive better outcomes.”
